About Jananom
Jananom is a Healthcare company based in Bengaluru (India) founded in 2018 by Chitra Murali and Murali Panchapagesa. It operates as a drug discovery, bio-analytical, and metabolic engineering services are provided. Jananom has raised $2.29 million across 2 funding rounds from investors including Startup Karnataka, Ganeshkumar Vikashini and Balachandar Nageswaran. Its Indian entity Jananom Private Limited reported revenue of ₹4.87 Cr. Its focus areas include Life Sciences, Genomics, Applied Genomics and Synthetic Biology. Its competitors include Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
Jananom was founded in 2018 and is based in Bengaluru, India. Operations focus on the biotechnology sector, with services encompassing drug discovery, bio-analytical testing, and metabolic engineering for small molecules and peptides. Genetic engineering and metabolic pathways are utilized by the team to develop compounds for applications in synthetic biology. Niche services are extended to global companies across various sectors.
- Headquarters Bengaluru, India
- Founders Chitra Murali, Murali Panchapagesa
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website jananom.com
- Social LinkedIn
- Legal Name Jananom Private Limited
- Date of Incorporation 03 Apr, 2018
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹4.87 Cr
FY 2025 · -11% YoY
- Net Profit₹65.3 Lakh
FY 2025 · 13% margin
- EBITDA₹1.03 Cr
FY 2025 · 21% margin
- Total Equity Funding$2.29M (USD)
in 2 rounds
- Latest Funding Round$2.29M (USD), Angel Round
Mar 2025
- InvestorsStartup Karnataka
& 2 more
Associated legal entities of Jananom
Jananom is associated with 2 registered companies on The Company Check; the primary company is Jananom Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jananom Private Limited CIN U72100KA2018PTC111856 | Active | 03 Apr 2018 | Bangalore, Karnataka | ₹4.9 Cr | – | 5 | View details |
| Jananom Natural Nutrition Private Limited CIN U15100TZ2019PTC032613 | Active | 22 Aug 2019 | Coimbatore, Tamil Nadu | ₹0.0 Cr | – | 3 | View details |
Funding Insights of Jananom
Jananom has successfully raised a total of $2.29M across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $2.29 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.29M
- Total Rounds 2
- Last Round Angel Round — $2.29M
- Investors Count 3
All 2 funding rounds of Jananom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $2.29M | Angel Round | – | Ganeshkumar Vikashini | |
| Jun 2018 | – | Grant | – | – |
3 investors in total: 1 institutional and 2 angel.
Investors in Jananom
Jananom has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Startup Karnataka, Ganeshkumar Vikashini and Balachandar Nageswaran.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
GV Ganeshkumar Vikashini | - | – | unknown_d86740a47a2642c98 | - |
BN Balachandar Nageswaran | - | – | unknown_38ec5ed1d85a4ba4a | - |
Investor details for Jananom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Jananom Private Limited (Jananom)
Jananom Private Limited is the primary company behind Jananom. The boards of the 2 registered companies of Jananom currently have 7 directors; the longest-serving is Chitra Murali, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chitra Murali DIN 02416919 | Director | 03 Apr 2018 | 8 yrs 6 mo | Jananom Private Limited, Jananom Natural Nutrition Private Limited |
| Murali Panchapagesa Muthuswamy DIN 00178914 | Director | 03 Apr 2018 | 8 yrs 6 mo | Jananom Private Limited |
| Shriram DIN 07896350 | Director | 19 Aug 2019 | 7 yrs 2 mo | Jananom Private Limited |
| Srinisha Murali Panchapagesa DIN 06481566 | Director | 22 Apr 2021 | 5 yrs 5 mo | Jananom Natural Nutrition Private Limited |
| Murali Hanushree DIN 09155803 | Director | 22 Apr 2021 | 5 yrs 5 mo | Jananom Natural Nutrition Private Limited |
| Gobichettipalayam Nageswaran Balachandar DIN 00002669 | Director | 04 Mar 2025 | 1 yr 7 mo | Jananom Private Limited |
| Jaganathan Ganesh Kumar DIN 00002658 | Director | 04 Mar 2025 | 1 yr 7 mo | Jananom Private Limited |
People of Jananom
2 people are tracked at Jananom (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Jananom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Jananom
Figures of Jananom Private Limited, the primary company behind Jananom, for FY 2025. Revenue was ₹4.87 Cr (-11% year on year). Net profit was ₹65.3 Lakh (13% margin). EBITDA was ₹1.03 Cr (21% margin). Revenue has grown at a compounded annual rate of +12% over three years and +44% over five years.
- ₹4.87 CrRevenue · FY 2025 · -11% YoY
- ₹65.3 LakhNet profit · 13% margin
- ₹1.03 CrEBITDA · 21% margin
- ₹1.7 LakhPaid-up capital
- +12%Revenue CAGR, 3 years
- +44%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Jananom Private Limited are on its company page.
Detailed financial statements for Jananom
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Jananom
3 dated milestones of Jananom across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Jananom is founded.
- Funding First funding round.
- Funding Latest funding round, Angel Round, of $2.3M.
Competitors of Jananom
Jananom has 10 listed competitors in our database, 7 of them funded. They include Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | – | 21,400 | Provider of drug discovery and preclinical development services | |
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | – | 9,321 | Provider of laboratory tests for physicians | |
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences | |
| frontagelab.com | 2001 | Exton, United States | $10.24M | – | Early drug development services are provided for pharma firms. | |
| canopybiosciences.com | 2016 | St. Louis, United States | $4.48M | – | Cell line engineering services are offered via CRISPR-Cas9 technology. | |
| precisionformedicine.com | 2013 | Bethesda, United States | $150M | – | Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices | |
| taimei.com | 2013 | Pleasanton, United States | $193.73M | – | A digital intelligence platform is focused on life sciences activities. | |
| scantox.com | 1977 | Lille Skensved, Denmark | – | 30 | Laboratory focused on providing pharmacology, toxicology, and histopathology services | |
| tenpointtherapeutics.com | 2020 | Cambridge, United Kingdom | $70M | – | Engineered cell-based therapeutics are developed to restore vision. |
Detailed competitors of Jananom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Jananom (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jananom
Jananom was founded in 2018.
Jananom is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Jananom is a funded company, having raised a total of $2.29M across 2 funding rounds to date.
The primary company behind Jananom, Jananom Private Limited, reported revenue of ₹4.87 Cr for FY 2025, down 11% year on year.
Jananom was founded in 2018 and is based in Bengaluru, India. Operations focus on the biotechnology sector, with services encompassing drug discovery, bio-analytical testing, and metabolic engineering for small molecules and peptides. Genetic engineering and metabolic pathways are utilized by the team to develop compounds for applications in synthetic biology. Niche services are extended to global companies across various sectors.
Jananom's top competitors include LabCorp, Charles River Laboratories and Cytel.
Jananom has 3 investors. Key investors include Startup Karnataka, Ganeshkumar Vikashini, and Balachandar Nageswaran.
Jananom is associated with 2 legal entities: Jananom Private Limited, Jananom Natural Nutrition Private Limited.
The legal entities of Jananom currently have 7 directors, including Chitra Murali, Shriram, Gobichettipalayam Nageswaran Balachandar and others.